Ghana's cabinet, chaired by President John Mahama, rejected a US-proposed healthcare agreement on April 28, 2026. The deal would have compelled Ghana to surrender its health statistics to the United States for 25 years. This agreement involved an initial GHS 1.4 billion (109 million US dollars) health package.
Government officials cited concerns over potential data breaches and sharing sensitive health data as the main reasons for this rejection. The proposed terms would have granted the US access to personal and population-level health information. This decision reflects a strong stance on protecting national health data integrity.
This rejection fits into a broader narrative of African nations asserting greater control over their resources and data. Zambia and Zimbabwe have also rejected similar US deals, citing sovereignty concerns. These deals are part of a shift by the US to encourage host nations to take more financial responsibility for their health systems. This aims to transition aid to self-reliance through its “America First Global Health Strategy”.
Critics argue that requirements for long-term access to national health data resemble “neo-colonial” extraction. They question why initial five-year agreements would demand data sharing for an additional 20 years. These one-sided bilateral agreements benefit the donor more than the recipient, according to some analysts.
The agreement would also have required Ghana to give up control over health decisions and resources. This was seen as a direct threat to national health sovereignty. The deal's terms demanded Ghana bypass parliamentary ratification, a necessary step for international agreements. This procedural concern further fueled the rejection.
Negotiations between the Donald Trump and John Mahama administrations began in November 2025. They ended without agreement due to increasing pressure and data access requirements. The total package offered to Ghana was GHS 4.09 billion (300 million US dollars) over time.
Eighteen other African countries have signed similar deals, totalling GHS 269.46 billion (19.8 billion US dollars) in new health funding. The US committed GHS 166.36 billion (12.2 billion US dollars) of this amount, with African countries committing GHS 103.10 billion (7.5 billion US dollars). These signing countries include Botswana, Nigeria, and Ethiopia.
Ghana's government, despite potential diplomatic pressure, appears committed to its decision. This rejection highlights a commitment to local resources and homegrown healthcare solutions. Initiatives like vaccine production and Agenda 111 hospitals should be sustained. The government plans to train more medical researchers and build professional capacity. This will strengthen Ghana's healthcare independence.
Analysts will watch for any diplomatic repercussions following Ghana's decision. This move sends a clear signal about Ghana's priorities regarding data privacy and national sovereignty. It could also influence future international aid negotiations across the continent.